Olmetyle C 40 Tablet is formulated with Olmesartan Medoxomil 40mg and Chlorthalidone 12.5mg, a powerful antihypertensive combination that helps in the effective control of high blood pressure. This dual-action therapy supports sustained blood pressure reduction and minimizes cardiovascular complications.
Olmesartan Medoxomil is an angiotensin II receptor blocker (ARB) that relaxes blood vessels and improves blood flow, while Chlorthalidone is a long-acting thiazide-like diuretic that helps eliminate excess salt and water from the body. Together, they provide enhanced and long-lasting antihypertensive control.
This combination is widely prescribed for patients who do not achieve adequate blood pressure control with monotherapy. It is suitable for long-term hypertension management and is commonly used in cardiology and internal medicine practice.
Adding Olmetyle C 40 Tablet to your cardiology and antihypertensive segment strengthens your product portfolio with a high-demand, clinically trusted combination. It offers excellent opportunities across hospital supply, retail distribution, institutional tenders, export markets, and third-party manufacturing.
Some patients may experience dizziness, headache, fatigue, increased urination, or electrolyte imbalance. Rarely, hypotension, dehydration, or renal function changes may occur.
Olmetyle C 40 Tablet is formulated with Olmesartan Medoxomil 40mg and Chlorthalidone 12.5mg, a powerful antihypertensive combination that helps in the effective control of high blood pressure. This dual-action therapy supports sustained blood pressure reduction and minimizes cardiovascular complications. Olmesartan Medoxomil is an angiotensin II receptor blocker (ARB) that relaxes blood vessels and improves blood flow, while Chlorthalidone is a long-acting thiazide-like diuretic that helps eliminate excess salt and water from the body. Together, they provide enhanced and long-lasting antihypertensive control. This combination is widely prescribed for patients who do not achieve adequate blood pressure control with monotherapy. It is suitable for long-term hypertension management and is commonly used in cardiology and internal medicine practice. Adding Olmetyle C 40 Tablet to your cardiology and antihypertensive segment strengthens your product portfolio with a high-demand, clinically trusted combination. It offers excellent opportunities across hospital supply, retail distribution, institutional tenders, export markets, and third-party manufacturing.
Use under medical supervision. Regular monitoring of blood pressure, kidney function, and electrolytes is recommended. Caution is advised in patients with renal impairment, dehydration, or electrolyte disturbances.
Store Olmetyle C 40 Tablet in a cool, dry place below 25°C, away from light and moisture. Keep out of reach of children.